Lightweight breast implants: a novel solution for breast augmentation and reconstruction mammaplasty

Jacky Govrin-Yehudain1, Haim Dvir1, Dina Preise1

  • 1Dr Govrin-Yehudain is President, Dr Haim is Chief Technology Officer, and Mr Govreen-Segal is Chief Executive Officer, G&G Biotechnology Ltd., Haifa, Israel. Dr Govrin-Yehudain is also Founding Plastic Surgeon, Beit Harofim Medical Center, Haifa, Israel. Dr Preise is a Senior Intern in the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. Mr Govrin-Yehudain is a Medical Student, Bar Ilan University, Ramat Gan, Israel.

Aesthetic Surgery Journal
|September 4, 2015
PubMed
Summary

Novel lightweight breast implants reduce tissue strain and deformation, improving long-term outcomes. This innovation addresses implant weight as a key factor in breast tissue compromise, enhancing patient safety and satisfaction.

Related Concept Videos